tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK

Cytokinetics (CYTK) Technical Analysis

969 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Cytokinetics’s (CYTK) Moving Averages Convergence Divergence (MACD) indicator is -0.75, suggesting Cytokinetics is a Sell.
Cytokinetics’s (CYTK) 20-Day exponential moving average is 53.59, while Cytokinetics’s (CYTK) share price is $54.84, making it a Buy.
Cytokinetics’s (CYTK) 50-Day exponential moving average is 56.95, while Cytokinetics’s (CYTK) share price is $54.84, making it a Sell.

Cytokinetics (CYTK) Pivot Points

Jul 02, 2024, 11:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
51.47
52.21
53.19
53.93
54.91
55.65
56.63
Fibonacci
52.21
52.86
53.27
53.93
54.58
54.99
55.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cytokinetics (CYTK) Moving Averages

Jul 02, 2024, 11:40 PM
Period
Simple
Exponential
MA5
53.46Buy
53.83Buy
MA10
53.12Buy
53.44Buy
MA20
52.87Buy
53.59Buy
MA50
57.21Sell
56.95Sell
MA100
64.34Sell
59.39Sell
MA200
56.18Sell
52.75Buy
Cytokinetics’s (CYTK) 10-Day exponential moving average is 53.44, while Cytokinetics’s (CYTK) share price is $54.84, making it a Buy.
Cytokinetics’s (CYTK) 100-Day exponential moving average is 59.39, while Cytokinetics’s (CYTK) share price is $54.84, making it a Sell.
Cytokinetics’s (CYTK) stock price is $54.84 and Cytokinetics’s (CYTK) 50-day simple moving average is 57.21, creating a Sell signal.
Cytokinetics’s (CYTK) stock price is $54.84 and Cytokinetics’s (CYTK) 100-day simple moving average is 64.34, creating a Sell signal.
Cytokinetics’s (CYTK) stock price is $54.84 and Cytokinetics’s (CYTK) 200-day simple moving average is 56.18, creating a Sell signal.

Cytokinetics (CYTK) Technical Indicators

Jul 02, 2024, 11:40 PM
Name
Value
Implied Action
RSI (14)
51.47
Neutral
STOCH (9,6)
79.02
Neutral
STOCHRSI (14)
78.22
Neutral
MACD (12,26)
-0.75
Sell
ADX (14)
20.72
Neutral
Williams %R
-22.99
Buy
CCI (14)
124.00
Sell
ATR (14)
2.42
-
Ultimate Oscillator
56.60
Neutral
ROC
1.00
Buy
Cytokinetics’s (CYTK) Relative Strength Index (RSI) is 51.47, creating a Neutral signal.
Cytokinetics’s (CYTK) Trend Strength Indicator (ADX) is 20.72, creating a Neutral signal.
Cytokinetics’s (CYTK) Commodity Channel Index (CCI) is 124.00, creating a Sell signal.
Cytokinetics’s (CYTK) Price Rate of Change (ROC) is 1.00, creating a Buy signal.

FAQ

Is CYTK a Buy, Hold, or Sell?
Based on CYTK’s technical indicators, CYTK is a Buy.
    What is CYTK’s RSI (14)?
    CYTK’s RSI (14) is 51.47, which suggests CYTK is a Neutral.
      What is CYTK’s MACD?
      CYTK’s MACD is -0.75, which suggests CYTK is a Sell.
        What is CYTK’s 5-day moving average?
        CYTK’s 5-day moving average is 53.46, which suggests CYTK is a Buy.
          What is CYTK’s 20-day moving average?
          CYTK 20-day moving average is 52.87, which suggests CYTK is a Buy.
            What is CYTK’s 50-day moving average?
            CYTK’s 50-day moving average is 57.21, which suggests CYTK is a Sell.
              What is CYTK’s 200-day moving average?
              CYTK’s 200-day moving average is 56.18, which suggests CYTK is a Sell.
                What is CYTK’s Williams % R (14)?
                CYTK’s Williams % R (14) is -22.99, which suggests CYTK is a Buy.
                  What is CYTK’s CCI (14)?
                  CYTK’s CCI (14) is 124.00, which suggests CYTK is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis